S0960-9822(22)011216, Jul
If this is true at an individual level, its even more true at a population level
One of the nations largest PBMs, run by CVS Health, dropped Zepbound from its national formulary, or list of covered drugs, on July 1 in favor of Wegovy

Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Mounjaro, DailyMed (2024) Savings & resources, Eli Lilly and Company (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) An open letter from Eli Lilly and Company regarding certain practices related to Mounjaro and Zepbound, Eli Lilly (2024) Compounding and the FDA: Questions and answers, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Leading Pharma Franchise & Third Party Manufacturer in India Biophar Lifesciences Pvt
No human dose has been established and no human trials exist